Adherence of tumor cells to endothelial monolayers: inhibition by lymphokines.
Tumor cells can adhere to endothelial cell monolayers in vitro. The kinetics of this reaction are rapid; 50% of maximal binding occurs by 30 min of incubation. In the case of the P815 mastocytoma, the maximal percentage of binding is approximately 70%, suggesting that there are both binding and nonbinding tumor cell populations. Binding is independent of tumor cell dose over a 200-fold range of cell concentrations. Lymphokine-containing preparations were found to markedly suppress the binding of either P815 mastocytoma or Ehrlich ascites cells to endothelium. This effect appeared to be due to both diminished attachment and enhanced dissociation. The activity is found in the same molecular weight range as tumor migration inhibition factor (TMIF), and is not found in preparations lacking TMIF activity. Thus, the factor may prove to be TMIF itself or a lymphokine related to it. Of equal interest is the possibility that it represents a previously undescribed factor.
D000818:Animals; D001667:Binding, Competitive; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology / Q000503:physiopathology*; D002417:Cattle; D002448:Cell Adhesion; D004727:Endothelium / Q000276:immunology / Q000502:physiology*; D006168:Guinea Pigs; D006801:Humans; D007166:Immunosuppressive Agents / Q000502:physiology*; D007700:Kinetics; D008222:Lymphokines / Q000502:physiology*; D012515:Mast-Cell Sarcoma / Q000276:immunology / Q000503:physiopathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA
D007166:Immunosuppressive Agents; D008222:Lymphokines